** Shares of Sino Biopharmaceutical 1177.HK climb 3.7% to HK$6.72, on course for the biggest one-day pct rise since January 7
** Stock hits highest since January 30 on its fifth straight session of gain
** Company said its unit's drug has completed patient enrollment in its Phase III registrational clinical trial for treatment of metastatic gastric and gastroesophageal junction adenocarcinoma
** YTD, stock up 7.6%, Hang Seng Biotech Index .HSBIO up 9.4%
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))